BSE filing, NSE: INDSOYA. Summary written from the filing by ALFA Finder's alert engine.
Indsoya Ltd: key numbers
- Share price
- ₹99.18
- Market cap
- ₹103.2 Cr
- Revenue (annual)
- ₹4.90 Cr
- Net profit (annual)
- ₹0.71 Cr
- P/E (TTM)
- 47.5×Sector 43.1×
- Promoter holding
- 66.58%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indsoya Ltd
All →Apollo Ingredients Other Announcement
Apollo Ingredients Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Apollo Ingredients Management Change
Apollo Ingredients Ltd disclosed resignation of CS & Compliance Officer Ayushi Agrawal effective 1 Oct 2026 due to personal reasons. No material reasons beyond personal were stated.
Apollo Ingredients Board Meeting Date
The company has scheduled a board meeting for September 22, 2026, to discuss sustainability initiatives, government tender participation, and potential healthcare diversification.
Manglam Global Corporations Annual General Meeting
Manglam Global Corporations Limited has issued a notice for an Extra-Ordinary General Meeting on September 16, 2026, to consider a preferential issue of 1 Crore equity shares.
- Value
- ₹10.25 Cr
Apollo Ingredients Q1 FY27 Results: Turns Profitable, Net Profit ₹1.2 Cr
Apollo Ingredients Ltd reported revenue from operations of ₹5.3 Cr (+783.3% YoY) and net profit of ₹1.2 Cr for Q1 FY27.
- Key figure
- Net profit ₹1.2 Cr
Apollo Ingredients Board Meeting Date
Apollo Ingredients Limited has scheduled a board meeting for August 10, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.
Other board meeting date announcements
All →Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.
Salzer Electronics Board Meeting Date
Salzer Electronics Limited intimated a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window closes from 1 October to 14 November 2026.
Ekansh Concepts Board Meeting Date
Ekansh Concepts has scheduled a board meeting for November 5, 2026, to consider Q2 and H1 FY27 un-audited financial results. No figures are disclosed.